Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

GCC Countries Anti-Viral Drugs Market Outlook (2016-2021) - Key Players are Abbott, Gilead & GlaxoSmithKline - Research and Markets

Research and Markets
Posted on: 23 Aug 16

Research and Markets has announced the addition of the "GCC Countries Anti-Viral drugs Market Outlook - Market size, Segmentation, Market Share and Competitive Landscape (2016-2021)" report to their offering.

In the year 2015, the GCC Countries Anti-Viral drugs market is expected to increase during the forecast period. Anti-Viral drugs are the drugs used to treat viral infections which can range from infections like flu to AIDS (Acquired Immuno Deficiency Syndrome). Just like common cold which is also caused by virus, most viral diseases are extremely difficult to cure and what the anti-viral drugs mostly do is slow down the reproduction of virus which in some cases enables immune system to eliminate the virus (as in case of flu) while slowing down the disease progression in other cases (as in case of AIDS).

The need of anti-viral drugs for patient's lifetime in case of diseases like HIV/AIDS along with well-established supply chain that facilitates easy procurement are driving the growth of this market. While the increasing use of generics along with lack of incentivization and lack of curative anti-viral drugs for indications like HIV/AIDS are hindering the growth of this market.

Lack of broad spectrum anti-viral drugs is currently the huge unmet need in this market and presents a great opportunity to companies. While the negative impact of viral vaccines on the growth of anti-viral drugs market and increasing focus on prevention rather than cure of viral diseases are currently the challenges faced by this market.

Companies Mentioned:

  • Abbott
  • Bristol-Myers-Squibb
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune/AstraZeneca
  • Merck & Co
  • Roche
  • Schering-Plough

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Key Challenges

5. Competitive Landscape

For more information about this report visit

Related Reports:

Related Topics: Infectious Disease Testing

View source version on

Business Wire

Last updated on: 23/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.